Maternal opioid dose is associated with neonatal abstinence syndrome in children born to women with sickle cell disease

American Journal of Hematology
Tyler ShirelJoshua J Field

Abstract

The objective of this study was to test the hypothesis that higher daily opioid dose is associated with the presence and severity of neonatal abstinence syndrome (NAS) in pregnant women with sickle cell disease (SCD). This was a retrospective study of pregnant women with SCD who required opioids. NAS was evaluated using the Finnegan scoring system and classified as none, mild, and severe. Severe NAS was defined as a Finnegan score ≥ 8 on 3 consecutive tests. Thirty-four pregnancies were examined in 30 women with SCD. Higher daily morphine dose was associated with a higher percentage of days in the hospital during pregnancy (P < 0.001). Hospital days contributed disproportionately to daily morphine dose as larger amounts of opioids were administered in the hospital compared to home (P = 0.002). Median maternal oral morphine dose was 416 mg for infants with severe NAS compared with 139 mg for those with mild NAS (P = 0.04). For infants with no NAS, median maternal morphine was 4 mg, significantly less than those with mild NAS (P < 0.001). Infants born to women who used on average >200 mg/day of oral morphine equivalent in the last month of pregnancy had a 13-fold increased risk of severe NAS compared with those who used <200 mg/d...Continue Reading

References

Oct 1, 1977·Early Human Development·S R KandallJ Lowinson
Jan 15, 1977·American Journal of Obstetrics and Gynecology·J D MaddenR Davis
Apr 1, 1975·Clinical Pediatrics·F Rahbar
Jul 4, 1991·The New England Journal of Medicine·O S PlattT R Kinney
Dec 6, 1973·The New England Journal of Medicine·C ZelsonM Casalino
Dec 7, 2002·Obstetrics and Gynecology·Jodi S DasheGeorge D Wendel
Sep 2, 2003·The British Journal of Psychiatry : the Journal of Mental Science·K JohnsonA Greenough
Jan 9, 2004·Archives of Disease in Childhood. Fetal and Neonatal Edition·C Sharpe, C Kuschel
Dec 21, 2004·Drug and Alcohol Dependence·Stefan LangenfeldMartin Theisohn
Oct 11, 2005·Hematology/oncology Clinics of North America·Kathryn Hassell
Nov 28, 2006·Public Health Nutrition·Clare PettingerMariette Gerber
Jul 7, 2007·Substance Use & Misuse·Lauren M JanssonHendrée E Jones
Jan 2, 2008·Pediatrics·Lauren M JanssonMarilyn A Huestis
Jan 16, 2008·Annals of Internal Medicine·Wally R SmithSusan D Roseff
Sep 5, 2008·The American Journal on Addictions·Hendrée E JonesMichelle Tuten
May 18, 2010·The Journal of Pediatrics·Neil S SeligmanJason K Baxter
Dec 15, 2010·The New England Journal of Medicine·Hendrée E JonesGabriele Fischer
Mar 2, 2012·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Ursula A PrithamMarie J Hayes
Aug 28, 2012·Blood·Samir K BallasPatricia Adams-Graves
Jan 15, 2013·Clinical Obstetrics and Gynecology·Michael K Lindsay, Erin Burnett
Feb 27, 2013·Pediatrics·Marylou BehnkeUNKNOWN Committee on Fetus and Newborn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Maternal and Child Health Journal
Karen A McQueenLindsay Desaulniers
International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
H Narchi, E Ekuma-Nkama
© 2022 Meta ULC. All rights reserved